Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interaction of Clopidogrel and Dabigatran in Healthy Males
NCT02171598Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of dabigatran in thromboembolism (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area Under the Curve, Maximum Plasma Concentration and 2 more. Started Feb 2009; status: completed.
02
Drugs
dabigatran
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02171598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02171598.